Detalles de la búsqueda
1.
An education resource for human papillomavirus oropharyngeal cancer patients: think-aloud interviews.
Support Care Cancer
; 31(3): 158, 2023 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36773108
2.
The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative study.
BMC Health Serv Res
; 23(1): 1073, 2023 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37803335
3.
Tissue-Like 3D Standard and Protocols for Microscope Quality Management.
Microsc Microanal
; 29(2): 616-634, 2023 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37749742
4.
Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control.
Int J Cancer
; 149(2): 297-306, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33634857
5.
Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis.
PLoS Med
; 18(3): e1003534, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33705382
6.
Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Lancet
; 395(10224): 575-590, 2020 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32007141
7.
Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
Lancet
; 395(10224): 591-603, 2020 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32007142
8.
Active surveillance as a management option for cervical intraepithelial neoplasia 2: An online experimental study.
Gynecol Oncol
; 161(1): 179-187, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33516531
9.
Achieving cervical cancer elimination among Indigenous women.
Prev Med
; 144: 106314, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33678228
10.
Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis.
Prev Med
; 144: 106276, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33678239
11.
Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis.
Prev Med
; 151: 106623, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34029578
12.
Australian National Cervical Screening Program renewal: Attitudes and experiences of general practitioners, and obstetricians and gynaecologists.
Aust N Z J Obstet Gynaecol
; 61(3): 416-423, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33512715
13.
Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions.
Gynecol Oncol
; 158(3): 710-718, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32723676
14.
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
Lancet Oncol
; 20(3): 394-407, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30795950
15.
The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications.
Gynecol Oncol
; 152(3): 472-479, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30876491
16.
Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia.
Gynecol Oncol
; 152(3): 465-471, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30876490
17.
How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country.
Int J Cancer
; 141(12): 2410-2422, 2017 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28801947
18.
Impact of the National Cervical Screening Programme in New Zealand by age: analysis of cervical cancer trends 1985-2013 in all women and in Maori women.
Cancer Causes Control
; 28(12): 1393-1404, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28986722
19.
Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries.
Int J Cancer
; 139(12): 2771-2780, 2016 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27541596
20.
Cost-effectiveness of nonavalent HPV vaccine in Norway considering current empirical data and validation.
Prev Med
; 150: 106688, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34303489